Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Plans To Restart Tanezumab Trials In 2014

Jul 30 2013

• By Jessica Merrill

Related Content

Anti-NGF Trials Might Resume With Very Narrow Patient Populations

Mar 19 2012

Regeneron, J&J, AstraZeneca Pull Plug On NGF Inhibitors In Development For Pain Indications

Dec 30 2010

As Eliquis Sales Lag, Bristol/Pfizer Take Action

Jul 25 2013

Related Companies

Pfizer Inc.

Bristol Myers Squibb Company

Additional Topics

Business Strategies Strategy BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window